Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab
Robertz J, Andres M, Mansouri Taleghani B, Koneth I, Binet F, Kremer Hovinga J. Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab. Am J Hematol 2019; 94:E259-E261.
Aug 9, 2019
Obinutuzumab in two patients suffering from immune-mediated thrombotic thrombocytopenic purpura intolerant to rituximab
Aug 9, 2019
Am J Hematol 2019; 94:E259-E261
Robertz Judith, Andres Martin, Mansouri Taleghani Behrouz, Koneth Irene, Binet Françoise-Isabelle, Kremer Hovinga Johanna A
more
